mifepristone Search Results


ru486  (Tocris)
94
Tocris ru486
Ru486, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ru486/product/Tocris
Average 94 stars, based on 1 article reviews
ru486 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
mifepristone mce  (MedChemExpress)
95
MedChemExpress mifepristone mce
Mifepristone Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone mce/product/MedChemExpress
Average 95 stars, based on 1 article reviews
mifepristone mce - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
mifepristone ru486  (Selleck Chemicals)
93
Selleck Chemicals mifepristone ru486
Mifepristone Ru486, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone ru486/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
mifepristone ru486 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
mif inhibitor  (MedChemExpress)
94
MedChemExpress mif inhibitor
Mif Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mif inhibitor/product/MedChemExpress
Average 94 stars, based on 1 article reviews
mif inhibitor - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
mifepristone  (steraloids inc)
90
steraloids inc mifepristone
Mifepristone, supplied by steraloids inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone/product/steraloids inc
Average 90 stars, based on 1 article reviews
mifepristone - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
p4  (TargetMol)
94
TargetMol p4
P4, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p4/product/TargetMol
Average 94 stars, based on 1 article reviews
p4 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
ru486  (LKT Laboratories)
86
LKT Laboratories ru486
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
Ru486, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ru486/product/LKT Laboratories
Average 86 stars, based on 1 article reviews
ru486 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier
mifepristone  (Tocris)
93
Tocris mifepristone
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
Mifepristone, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone/product/Tocris
Average 93 stars, based on 1 article reviews
mifepristone - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
mifepristone  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology mifepristone
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
Mifepristone, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mifepristone - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
n demethyl mifepristone d230950  (Toronto Research Chemicals)
88
Toronto Research Chemicals n demethyl mifepristone d230950
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
N Demethyl Mifepristone D230950, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n demethyl mifepristone d230950/product/Toronto Research Chemicals
Average 88 stars, based on 1 article reviews
n demethyl mifepristone d230950 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier
pa5  (Thermo Fisher)
94
Thermo Fisher pa5
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
Pa5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pa5/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
pa5 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
mifepristone  (Hirschmann)
90
Hirschmann mifepristone
( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by <t>RU486</t> (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.
Mifepristone, supplied by Hirschmann, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mifepristone/product/Hirschmann
Average 90 stars, based on 1 article reviews
mifepristone - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by RU486 (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.

Journal: Scientific Reports

Article Title: Glucocorticoid affects dendritic transport of BDNF-containing vesicles

doi: 10.1038/srep12684

Figure Lengend Snippet: ( a ) DEX-induced enhancement of BDNF vesicle transport was blocked by RU486 (mifepristone, a GR antagonist). Data were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 302, 181, 258, and 196 vesicles, respectively. *** P < 0.001 for the difference between moving (antero-, retro-grade, and back & forth) vs. stationary vesicles, student’s t -test. ( b ) The proportion of stationary vesicles in each condition was summarized. *** P < 0.001, ** P < 0.01. Statistical significance was evaluated by two-way ANOVA followed by Bonferroni post-hoc test. ( c ) RU486 partially suppressed the increased velocity of BDNF vesicle transport after DEX treatment. Velocities were obtained from 8 (CON), 6 (DEX), 7 (RU), and 6 (DEX + RU) neurons from three independent culture preparations including 40 (CON), 37 (DEX), 23 (RU), and 20 (DEX + RU) vesicles. CON (median 0.45 μm/sec, percentiles 0.4–0.5); DEX (median 0.8 μm/sec, percentiles 0.6–1.1); RU (median 0.4 μm/sec, percentiles 0.4–0.6); DEX + RU (median 0.5 μm/sec, percentiles 0.4–0.88). Circles outside the whiskers indicate outliers. *** P < 0.001, ** P < 0.01, Kruskal-Wallis test.

Article Snippet: RU486 (Mifepristone, 1 μM, LKT Laboratories Inc., MN) was applied 20 min before starting DEX treatment.

Techniques:

( a ) DEX (1 and 10 μM, for 24 h) significantly increased Htt expression in cortical neurons. (n = 5). *P < 0.05 vs. CON, one-way ANOVA followed by Bonferroni post-hoc test. ( b ) Pretreatment with RU486 blocked the effect of DEX on Htt expression levels (n = 8). *** P < 0.001, ** P < 0.01, n.s. means not significantly different ( P > 0.05), two-way ANOVA followed by Bonferroni post-hoc test. Htt: huntingtin. The gels have been run under the same experimental condition in each experiment. Original blot images before cropping are shown in .

Journal: Scientific Reports

Article Title: Glucocorticoid affects dendritic transport of BDNF-containing vesicles

doi: 10.1038/srep12684

Figure Lengend Snippet: ( a ) DEX (1 and 10 μM, for 24 h) significantly increased Htt expression in cortical neurons. (n = 5). *P < 0.05 vs. CON, one-way ANOVA followed by Bonferroni post-hoc test. ( b ) Pretreatment with RU486 blocked the effect of DEX on Htt expression levels (n = 8). *** P < 0.001, ** P < 0.01, n.s. means not significantly different ( P > 0.05), two-way ANOVA followed by Bonferroni post-hoc test. Htt: huntingtin. The gels have been run under the same experimental condition in each experiment. Original blot images before cropping are shown in .

Article Snippet: RU486 (Mifepristone, 1 μM, LKT Laboratories Inc., MN) was applied 20 min before starting DEX treatment.

Techniques: Expressing